Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Avalo Therapeutics (AVTX) Asset Utilization Ratio (2016 - 2025)

Avalo Therapeutics filings provide 10 years of Asset Utilization Ratio readings, the most recent being 0.0 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 16.96% to 0.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0, a 16.96% increase, with the full-year FY2025 number at 0.0, down 91.4% from a year prior.
  • Asset Utilization Ratio hit 0.0 in Q4 2025 for Avalo Therapeutics, up from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.56 in Q2 2023 to a low of 0.0 in Q3 2025.
  • Median Asset Utilization Ratio over the past 5 years was 0.08 (2022), compared with a mean of 0.15.
  • Biggest five-year swings in Asset Utilization Ratio: soared 739.91% in 2022 and later plummeted 98.76% in 2024.
  • Avalo Therapeutics' Asset Utilization Ratio stood at 0.06 in 2021, then surged by 739.91% to 0.52 in 2022, then crashed by 85.17% to 0.08 in 2023, then plummeted by 95.38% to 0.0 in 2024, then rose by 16.96% to 0.0 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.0 (Q4 2025), 0.0 (Q3 2025), and 0.0 (Q4 2024) per Business Quant data.